Bumper Offer - Urjas oil Just @ Rs. 1
Rosycap Gold 10/75 Mg Capsule is a prescription drug, available for use as Capsule. Rosycap Gold 10/75 Mg Capsule also has some secondary and off-label uses. These are listed below.
The correct dosage of Rosycap Gold 10/75 Mg Capsule depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
The most common side effects of Rosycap Gold 10/75 Mg Capsule are Chest Pain. Some other side effects of Rosycap Gold 10/75 Mg Capsule have been listed ahead. Normally, these side effects of Rosycap Gold 10/75 Mg Capsule are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Rosycap Gold 10/75 Mg Capsule's effect is Moderate during pregnancy and Mild for lactating mothers. Further, the section on Rosycap Gold 10/75 Mg Capsule related warnings talks about Rosycap Gold 10/75 Mg Capsule's effects on the liver, heart and kidney.
Rosycap Gold 10/75 Mg Capsule is contraindicated in people with pre-existing medical conditions like Asthma, Gout, Reye's syndrome as it can result in adverse effects. Other contraindications of Rosycap Gold 10/75 Mg Capsule have been discussed in the sections ahead.
Additionally, Rosycap Gold 10/75 Mg Capsule may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Rosycap Gold 10/75 Mg Capsule is safe while driving, and is is addictive in nature.
Rosycap Gold 10/75 Mg Capsule is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Rosycap Gold 10/75 Mg Capsule is used -
Severe
Moderate
Mild
Common
Is the use of Rosycap Gold 10/75 Mg Capsule safe for pregnant women?
Rosycap Gold can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Rosycap Gold right away. Take your doctor's advice before taking it again.
Is the use of Rosycap Gold 10/75 Mg Capsule safe during breastfeeding?
Rosycap Gold may have very limited harmful effects for breastfeeding women.
What is the effect of Rosycap Gold 10/75 Mg Capsule on the Kidneys?
Rosycap Gold has very mild side effects on the kidneys.
What is the effect of Rosycap Gold 10/75 Mg Capsule on the Liver?
The liver can be affected by Rosycap Gold. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rosycap Gold only after medical advice.
What is the effect of Rosycap Gold 10/75 Mg Capsule on the Heart?
Rosycap Gold is rarely harmful for the heart.
Rosycap Gold 10/75 Mg Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Rosycap Gold 10/75 Mg Capsule unless your doctor advises you to do so -
Is this Rosycap Gold 10/75 Mg Capsule habit forming or addictive?
Rosycap Gold 10/75 Mg Capsule is not addictive in nature.
Interaction between Food and Rosycap Gold 10/75 Mg Capsule
When consumed with certain foods, Rosycap Gold 10/75 Mg Capsule may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Rosycap Gold 10/75 Mg Capsule
Information about the interaction of Rosycap Gold 10/75 Mg Capsule and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Durlaza (aspirin)
KD Tripathi. Essentials of Medical Pharmacology. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 195-199
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 191-194
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Plavix (clopidogrel bisulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 630-631
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 335-336